Drug-Coated Versus Plain Balloon Angioplasty for Infrapopliteal Arterial Disease and Tissue Necrosis: A Randomized Controlled Study

Objective: To compare the safety and effectiveness of drug-coated balloon (DCB) and plain balloon angioplasty (PBA) in treating infrapopliteal (IP) atherosclerotic artery lesions in patients suffering from ischaemic tissue necrosis.Patients and Methods: The study included 80 consecutive adult patients who had infra-popliteal atherosclerotic artery lesions causing ischaemic tissue necrosis. From early December 2021 to the end of November 2023, 40 patients received PBA treatment and 40 had DCB angioplasty in a 1:1 randomisation scheme. Primary patency, Rutherford category change, mean diameter restenosis, binary restenosis, and all-cause mortality over a 12-month follow-up period were the primary outcome parameters. Procedural, technical success, major amputation, wound healing, major adverse limb events (MALE), reclusion, target lesion revascularisation (TLR), and change in ankle-brachial index between baseline and follow-up were the secondary outcomes.Results: Regarding baseline lesions characteristics and procedure data, there were no statistically significant variations between the two groups (P>.05). At the 12-month follow-up, the DCB group's main patency was much superior (75.7% vs. 59.3%, P<0.001). The DCB arm had a considerably lower 12-month mean diameter restenosis than the PBA group (27.8±3.2% vs. 44.9±3.8%, P<0.001). Compared to the PBA group, DCB patients had considerably reduced binary (≥50% diameter stenosis) restenosis rates (27% vs. 46%, P<0.001). Additionally, DCB patients had a considerably lower incidence of clinically-driven target lesion revascularisation (CD-TLR) than the PBA group (3.03% vs. 15.6%, P<0.001). Neither research group experienced any fatalities from procedures or devices.Conclusions: The treatment of Infrapopliteal arterial disease with DCB is more effective than PBA and associated with less restenosis, while the safety profile showed no significant difference between both treatment methods.

Authors

Institutions

Publication Details

Journal
The Egyptian Journal of Surgery
Published
2025-10-01
DOI
https://doi.org/10.21608/ejsur.2025.373163.1444
Primary Topic
Peripheral Artery Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drug-Coated Versus Plain Balloon Angioplasty for Infrapopliteal Arterial Disease and Tissue Necrosis: A Randomized Controlled Study

Mohamed A. Elheniedy, Adel Hussieny Kamhawy, Ahmed Elbarbary, Mohamed Mosa Sharaf
The Egyptian Journal of Surgery
Peripheral Artery Disease Management
article

Drug-Coated Versus Plain Balloon Angioplasty for Infrapopliteal Arterial Disease and Tissue Necrosis: A Randomized Controlled Study

Mohamed A. Elheniedy, Adel Hussieny Kamhawy, Ahmed Elbarbary, Mohamed Mosa Sharaf
article en

Abstract

Objective: To compare the safety and effectiveness of drug-coated balloon (DCB) and plain balloon angioplasty (PBA) in treating infrapopliteal (IP) atherosclerotic artery lesions in patients suffering from ischaemic tissue necrosis.Patients and Methods: The study included 80 consecutive adult patients who had infra-popliteal atherosclerotic artery lesions causing ischaemic tissue necrosis. From early December 2021 to the end of November 2023, 40 patients received PBA treatment and 40 had DCB angioplasty in a 1:1 randomisation scheme. Primary patency, Rutherford category change, mean diameter restenosis, binary restenosis, and all-cause mortality over a 12-month follow-up period were the primary outcome parameters. Procedural, technical success, major amputation, wound healing, major adverse limb events (MALE), reclusion, target lesion revascularisation (TLR), and change in ankle-brachial index between baseline and follow-up were the secondary outcomes.Results: Regarding baseline lesions characteristics and procedure data, there were no statistically significant variations between the two groups (P>.05). At the 12-month follow-up, the DCB group's main patency was much superior (75.7% vs. 59.3%, P<0.001). The DCB arm had a considerably lower 12-month mean diameter restenosis than the PBA group (27.8±3.2% vs. 44.9±3.8%, P<0.001). Compared to the PBA group, DCB patients had considerably reduced binary (≥50% diameter stenosis) restenosis rates (27% vs. 46%, P<0.001). Additionally, DCB patients had a considerably lower incidence of clinically-driven target lesion revascularisation (CD-TLR) than the PBA group (3.03% vs. 15.6%, P<0.001). Neither research group experienced any fatalities from procedures or devices.Conclusions: The treatment of Infrapopliteal arterial disease with DCB is more effective than PBA and associated with less restenosis, while the safety profile showed no significant difference between both treatment methods.

The Egyptian Journal of SurgeryVol. 44(4)
Tanta University (EG)
Openalex Percentile: Top 43%
Peripheral Artery Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.